Articles Tagged With:
-
Case Management Program Aims to Save Lives of Opioid Users in Kentucky
Case management can help some of the most challenging clients, such as people who are returning from jail and who are struggling with opioid use disorder. A study of people with opioid use issues in rural Kentucky revealed a case management program could help them improve their lives, help them remain substance-free, and stay out of jail.
-
FDA Authorizes Updated Boosters to Protect Against Omicron
Agency prepares for potential cold weather COVID-19 case spike with latest vaccine solution.
-
Is It Possible to Sway Hesitant Patients to Take the COVID-19 Vaccine?
A survey conducted in a small New York county reveals some challenges moving forward.
-
COVID-19 Infection More Likely to Inflame Heart Than Vaccine
Researchers noted patients were much more likely to be afflicted with myocarditis after a SARS-CoV-2 infection than after receiving a vaccine.
-
Promote Safety Helmet Use Among Children
The American Academy of Pediatrics encourages precautionary measures to prevent sports-related head injuries.
-
U.S. N95 Respirator Supply Finally Deemed Adequate
Federal regulators remove devices from shortage list.
-
Lack of Brain Temperature Variation May Predict Mortality Among Patients with Brain Injury
Variations in brain temperature appear to be a normal physiological variable. An absence of brain temperature variation may be a novel predictor of mortality among patients with brain injury.
-
Inclusion Body Myositis
This is a population-based study of inclusion body myositis (IBM) patients from a region of Sweden over a 33-year period. IBM presents later in life and has an unusual pattern of weakness with finger flexion, quadriceps, and swallowing muscles affected. Although it is described as an inflammatory myopathy, it does not respond to any immune-suppressive medications. It is a progressive disorder that reduces lifespan.
-
Thymectomy for Treatment of Myasthenia Gravis
In this retrospective study of the long-term benefit of thymectomy (median follow-up = 89.5 months), only half of those who had an initial positive response showed a sustained response. There was no clinical factor that predicted a long-term response.
-
Predicting Coma Recovery in Critically Ill COVID-19 Patients
The COVID-19 pandemic presented us with an unprecedented number of critically ill patients with coma. These investigators determined that the degree of hypoxemia determined the depth and duration of coma, but recovery was much better than expected and could be delayed by several weeks.